Share capital increase from exercise of warrants

22 Dec 2022 12:43 CET

Oslo, Norway, December 22, 2022 - As a consequence of exercise of 790,000
warrants in Nykode Therapeutics ASA with expiry date December 31, 2022, the
share capital of Nykode Therapeutics ASA has increased by NOK 7,900.00 from NOK
2,939,043.09 to NOK 2,946,943.09. The number of outstanding shares in the
company has increased by 790,000 from 293,904,309 to 294,694,309, each with a
par value of NOK 0.01. The warrants were exercised by an employee at a
subscription price of NOK 4.0 per share.

More information:
Access the news on Oslo Bors NewsWeb site